Cut in pharmaceutical prices worries domestic industry

Published: 2002-10-22 06:59:00

Updated: 2002-10-22 06:59:00

The turmoil surrounding imminent reduction of insurance drug prices is mounting in the domestic pharmaceutical industry, as the government is pushing ahead of a new drug price re-evaluation system as a means of improving the fiscal health of medical insurance to remove the bubble of drug prices.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK